The purpose of the Clinical Data and Outcomes Core is to provide longitudinal clinical, laboratory, and specimen locating data efficiently, and safely to basic, clinical, health services research, and epidemiological investigators affiliated with the UCSD CFAR. The large volume of both basic and clinical research conducted within the CFAR assures that, if appropriate datasets and querying capability were available, many opportunities for translational research would arise. Specifically, the goals of this core are to: 1. Facilitate more uniform and comprehensive assessment of key variables across clinical HIV sites at UCSD to facilitate the conduct of basic, clinical, epidemiologic, health services, and translational research; 2. To develop a data warehouse to facilitate linking of data from various sources for the purpose of constructing new datasets to support CFAR administration as well as feasibility and definitive studies; and, 3. To collaborate in and initiate projects relating laboratory, clinical, and health system/social/economic findings. We anticipate that this core will be useful to: a) basic science investigators in need of clinical correlates of patients whose specimens are being analyze, or wishing to select specimens based on specific characteristic; b) clinical investigators needing to know distributions of clinical or laboratory parameters for potential study populations to estimate sample or effects sizes for proposal preparation; c) investigators needing outcome information (e.g. survival, quality of life measures, CD4 and viral load outcomes) on subsets of patients of interest and; (d) investigators wanting to conduct observation studies prospective or retrospectively by assembling cohorts with defined characteristics that are recorded in the primary health care or clinical databases maintained by CFAR affiliated investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI036214-08S1
Application #
6500683
Study Section
Project Start
2001-09-30
Project End
2002-05-31
Budget Start
Budget End
Support Year
8
Fiscal Year
2001
Total Cost
$180,480
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Naticchia, Matthew R; Laubach, Logan K; Tota, Ember M et al. (2018) Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture. ACS Chem Biol 13:2880-2887
Blumenthal, Jill; Jain, Sonia; Mulvihill, Evan et al. (2018) Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr :
Kardava, Lela; Sohn, Haewon; Youn, Christine et al. (2018) IgG3 regulates tissue-like memory B cells in HIV-infected individuals. Nat Immunol 19:1001-1012
Wagner, Karla D; Syvertsen, Jennifer L; Verdugo, Silvia R et al. (2018) A mixed methods study of the social support networks of female sex workers and their primary noncommercial male partners in Tijuana, Mexico. J Mix Methods Res 12:437-457
Bastos, Francisco I; Bastos, Leonardo Soares; Coutinho, Carolina et al. (2018) HIV, HCV, HBV, and syphilis among transgender women from Brazil: Assessing different methods to adjust infection rates of a hard-to-reach, sparse population. Medicine (Baltimore) 97:S16-S24
Cepeda, Javier A; Eritsyan, Ksenia; Vickerman, Peter et al. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV 5:e578-e587
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Huang, Mia L; Michalak, Austen L; Fisher, Christopher J et al. (2018) Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State. Stem Cells 36:45-54
Skaathun, Britt; Voisin, Dexter R; Cornwell, Benjamin et al. (2018) A Longitudinal Examination of Factors Associated with Network Bridging Among YMSM: Implications for HIV Prevention. AIDS Behav :

Showing the most recent 10 out of 921 publications